|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2021
12 months to Jun 30, 2022
|
FY2020
12 months to Jun 30, 2021
|
|
|---|---|---|---|---|---|
| Sales, net | |||||
| Grant revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Goodwill impairment | |||||
| Loss on disposal of property and equipment | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Non-operating income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Interest and other expense | |||||
| Interest and other expense, net | |||||
| Other income from a related party (Note 3) | |||||
| Equity in loss of affiliate | |||||
| Total non-operating income, net | |||||
| Net loss from continuing operations | |||||
| Net gain (loss) from discontinued operations | |||||
| Net loss before deferred income tax benefit | |||||
| Deferred income tax benefit | |||||
| Net loss | |||||
| Basic and diluted loss per share: | |||||
| Loss from continuing operations, Basic | |||||
| Loss from continuing operations, Diluted | |||||
| Gain (loss) from discontinued operations, Basic | |||||
| Gain (loss) from discontinued operations, Diluted | |||||
| Basic loss per share | |||||
| Diluted loss per share | |||||
| Weighted average number of common shares used in computing net loss per share, basic and diluted: | |||||
| Basic | |||||
| Diluted | |||||
| Unrealized gain (loss) on available-for-sale securities | |||||
| Comprehensive loss | |||||
Loading...